Drug Induced Movement Disorders, Second Edition

Copyright © 2005 by Blackwell Publishing

Drug Induced Movement Disorders, Second Edition

Editor(s): Stewart A. Factor, Anthony E. Lang, William J. Weiner

Published Online: 14 JAN 2008

Print ISBN: 9781405126199

Online ISBN: 9780470753217

DOI: 10.1002/9780470753217

About this Book

Product Information

About The Product

The second revised edition of this text will update and present current state of the art clinical approaches to this subject. This book will continue to be the source text of information on drug-induced movement disorders authored and edited by the pioneers in the field. It will be an invaluable addition to the library of any neurologist.

Table of contents

    1. You have free access to this content
      Frontmatter (pages i–xiv)

  2. Part 1: General Considerations

    1. Chapter 1

      Movement Disorders: an Overview (pages 3–19)

      Martin Cloutier and Anthony E. Lang

    2. Chapter 2

      Rating Scales for Movement Disorders (pages 20–29)

      Ikwunga Wonodi, Elliot L. Hong, Matthew T. Avila and Gunvant K. Thaker

    3. Chapter 3

      Spontaneous Movement Disorders in Psychiatric Patients (pages 30–52)

      Irene Richard, Christopher O'Brien and Roger Kurlan

  3. Part 2: Antipsychotics

    1. Chapter 4

      The Pharmacology of Typical and Atypical Antipsychotics (pages 55–71)

      Gary Remington and Shitij Kapur

    2. Chapter 5

      Acute Drug-Induced Dystonia (pages 72–102)

      Michael F. Mazurek and Patricia I. Rosebush

    3. Chapter 6

      Drug-Induced Parkinsonism (pages 103–139)

      Joseph H. Friedman, Martha E. Trieschmann and Hubert H. Fernandez

    4. Chapter 7

      Acute Drug-Induced Akathisia (pages 140–173)

      Lenard A. Adler, John Rotrosen and Burt Angrist

    5. Chapter 8

      Neuroleptic Malignant Syndrome (pages 174–212)

      Stewart A. Factor

    6. Chapter 9

      Tardive Dyskinesia (pages 213–256)

      Thomas M. Hyde, Jose A. Apud, Whitney C. Fisher and Michael F. Egan

    7. Chapter 10

      Neuroleptic-Induced Tardive Dyskinesia Variants (pages 257–284)

      Frank Skidmore, William J. Weiner and Robert Burke

    8. Chapter 11

      Movement Disorders Due to Atypical Antipsychotics (pages 285–301)

      Karen E. Anderson

    9. Chapter 12

      Commentary: Is Tardive Dyskinesia Disappearing? (pages 302–310)

      James B. Lohr

  4. Part 3: Dopaminomimetic Drugs

    1. Chapter 13

      Dyskinesia Induced by Levodopa and Dopamine Agonists in Patients with Parkinson's Disease (pages 313–350)

      John G. Nutt and Matthew A. Brodsky

    2. Chapter 14

      Movement Disorders and Dopaminomimetic Stimulant Drugs (pages 351–370)

      Anthony E. Munson, Juan Sanchez-Ramos and William J. Weiner

  5. Part 4: Other Drugs

    1. Chapter 15

      Antidepressants (pages 373–407)

      Maria L. Moro-de-Casillas and David E. Riley

    2. Chapter 16

      Antiepileptics (pages 408–429)

      John C. Morgan and Madaline B. Harrison

    3. Chapter 17

      Miscellaneous Drug-Induced Movement Disorders (pages 430–441)

      Daniel Tarsy

    1. You have free access to this content
      Index (pages 442–466)

SEARCH